Hosted on MSN18h
MoCo Minute | REGENXBIO leads the charge in gene therapy for rare diseases
As the world recognizes Rare Disease Day on Feb. 28, Rockville-based biotechnology company, REGENXBIO is working to change ...
BioPharma Dive19h
AstraZeneca’s next breast cancer drug; Madrigal’s accelerating MASH launch
The British drugmaker claimed study success in a first-line setting in breast cancer. Elsewhere, Rezdiffra sales continued to ...
The American Journal of Managed Care21h
Real-World Data and Ongoing Research Into Bimekizumab-bkzx
Jeffrey Stark, MD, vice president, head of medical immunology, UCB, discusses ongoing clinical trials and the development of ...
STAT21h
Pharmalittle: We’ve reading about abortion pill maker entering legal fight, a bill to revise IRA, and more
GenBioPro, the largest manufacturer of abortion pills in the U.S., is wading into a federal court case over abortion access ...
BioSpace21h
Trump’s Pharma Tariffs, Another GLP-1 Compounding Lawsuit, Bluebird’s Bailout, More
As FDA seeks to rehire some fired employees, Donald Trump threatens to enact tariffs on pharma companies unless they reshore manufacturing; another lawsuit hits the complex GLP-1 compounding space as ...